Welcome Remarks

Alan Donnelly, Convenor of The G20 Health and Development Partnership

Ali Aslan, International TV Presenter, Moderator and Journalist


Ambassador Katharina Stasch, German Ambassador to the UN and other International Organizations

Febrian Ruddyard, Permanent Representative of Indonesia to the United Nations Office, Geneva

Fireside chat: In Conversation with…

Soumya Swaminathan, Chief Scientist, WHO

Stephen Twigg, Secretary General, Commonwealth Parliamentary Association

Panel 1

Digital Health – a fundamental pillar to strengthen the global health architecture 

Lakshmi Balachandran, Senior Director, Digital Health, Clinton Health Access Initiative, Inc.

Alain B. Labrique, Director Digital Health, World Health Organization, WHO 

Rajendra Pratap Gupta, Chairman, Dynamic Coalition on Digital Health, Internet Governance Forum

Giorgio Moretti, Founder and Chairman, Dedalus Group

Annalisa Pawlosky, Senior Research Analyst, Google

Omar Najim, Director, Executive Affairs Office, Abu Dhabi Department of Health

Bert Hartog, R&D Operations, Senior Director, Clinical Innovation, Janssen

Tamer H. Farag, Health Partner Innovation, Meta

Panel 2

What are the global best practice initiatives developed in G7, G20 and beyond during the pandemic? How can we make them more sustainable and strengthen efficient multilateral cooperation?

Thomas Cueni, Director General, IFPMA

Bill Rodriguez, CEO, FIND

Janet Ginnard, Head of Strategy, Unitaid

Saleh Al Ali, Executive Director, Emergency Centre, Department of Health Abu Dhabi

Marie-Ange Saraka-Yao, Managing Director and Director of Resource Mobilization, private Sector Partnerships, Innovative Finance Department, Gavi

Osamu Kunii, Chief Executive Officer, Global Health Innovative Technology Fund

Johan Vekemans, Senior Science and Clinical Advisor, IAVI

Lunch and Exhibition of G20HDP Partners on their work during COVID-19

Panel 3

Strengthening the global health architecture in the aftermath of COVID-19

Petro Terblanche, Managing Director, Afrigen Biologics

Philippe Francois, Senior Vice President, Global Supply, Becton, Dickinson and Company

Najat Mokhtar, Deputy Director General of Nuclear Science and Application, International Atomic Energy Agency, IAEA

Pierre Delsaux, Director-General, DG HERA

Sulaiman Saleh Al-Dakheel, General Manager, Gulf Health Council

Etleva Kadilli, Director Supply Division, UNICEF

Charles Gore, Executive Director, Medicines Patent Pool

David Reddy, CEO Medicines for Malaria Venture (MMV); Member of the Board, Coalition for Epidemic Preparedness Innovations, CEPI

Fireside chat

The two big killers worldwide – cardiovascular diseases and tuberculosis

Nick Herbert (Lord Herbert of South Downs), Chairman Global TB Caucus, Member House of Lords

Lucica Ditiu, Executive Director, Stop TB Partnership 

Peter Krustrup, Professor of Sport and Health Sciences, University of Southern Denmark

Ricardo Baptista Leite, Founder and President, UNITE

Panel 4

Why is cardiovascular disease the number one killer worldwide despite being preventable? 

Téa Collins, Lead, Global NCD Platform, Office of the Deputy Director-General, World Health Organization

Haseeb Ahmad, President Europe, Novartis

Kausik Ray, Professor of Public Health, Imperial College

Mathias Egermark, Senior Vice President Cardiometabolic Diseases Area Network, Roche Diagnostics

Dr Bente Mikkelsen, Director, WHO Department of Noncommunicable Diseases

Rifat Atun, Professor Harvard University, School of Public Health

Hasbullah Thabrany, Lead Co-Chair, Global Health Security and COVID-19 Task Force, T20 Indonesia

Panel 5

Where is AMR within the restructuring of the global health architecture? 

Hanan Balkhy, Assistant Director General, Antimicrobial Resistance, WHO

Najat Mokhtar, Deputy Director General of Nuclear Science and Application, International Atomic Energy Agency, IAEA

Adam Zerda, Senior Director, International Affairs Becton, Dickinson and Company (BD)

Henry Skinner, CEO, AMR Action Fund

Kevin Outterson, Executive Director, Carb-X

Marc Gitzinger, CEO and Co-Founder, BioVersys

James Anderson, Executive Director, Global Health, IFPMA

Concluding remarks and outlook to G20 health ministers meeting 

Alan Donnelly, Convenor of The G20 Health and Development Partnership

Networking and Drinks